drug

lebrikizumab-lbkz

1 story · latest Aug 5, 2026

Status: FDA approved Sep 2024 · BLA761306
Brand: Ebglyss

Relationships

Developed by Eli Lilly

Timeline

Lilly raises 2026 revenue guidance to $85-87 billion on Mounjaro, Zepbound growth

Aug 5Quarterly updateEli Lilly tirzepatide

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.